Lite Bites

LiteBites was a specialized medical nutrition company focused on developing innovative food products for patients with rare metabolic disorders, such as phenylketonuria (PKU) and tyrosinemia. The company's primary focus was on creating low-protein, phenylalanine-free medical foods that improved dietary compliance and quality of life for patients requiring strict metabolic management. Their product line included specialized snacks and nutritional supplements designed to be both palatable and therapeutically effective. LiteBites was eventually acquired by Applied Pharma Research (APR), which was subsequently integrated into Relief Therapeutics, to bolster their portfolio in the rare disease and metabolic health space.